Literature DB >> 26137164

Relative quantitative expression of hypoxia-inducible factor-1α, -2α and -3α, and vascular endothelial growth factor A in laryngeal carcinoma.

Todor Miroslavov Popov1, Teodora Goranova2, Gergana Stancheva2, Radka Kaneva2, Tihomir Dikov3, Ivan Chalakov1, Julian Rangachev1, Dimitar Konov1, Spiridon Todorov1, Orlin Stoyanov1, Vanio Mitev2.   

Abstract

The aim of the present study was to determine the relative quantitative expression of hypoxia-inducible factor (HIF)-1α, -2α and -3α, and VEGF-A in laryngeal carcinoma. A total of 63 patients with carcinoma of the larynx were enrolled in the study. Total RNA was isolated from fresh, frozen normal and tumor tissues of each patient, and quantitative polymerase chain reaction was performed. HIF-1α was upregulated in the majority of patients (44 patients; 69.84%). By contrast, only 7 (11.11%) patients from the whole group displayed HIF-2α overexpression, while the HIF-3α isoform was silenced in the majority of patients (48 patients, 76.19%). A small group of 5 (7.94%) patients exhibited significant overexpression of the HIF-3α isoform. VEGF-A expression was significantly higher (P<0.05) in patients with upregulated HIF-1α (2.72±1.41 RQ) compared with patients without upregulated HIF-1α (1.86±1.46 RQ). There was a moderate positive correlation between mRNA expression levels of HIF-1α and VEGF-A (rs=0.392; P<0.005). To the best of our knowledge, this study is first to report quantitative data with regard to the expression of all three HIF isoforms in malignant neoplasms. The findings suggest the existence of specific phenotypes of HIF expression in laryngeal carcinoma, where the HIF switch is absent.

Entities:  

Keywords:  hypoxia-inducible factor-1α; hypoxia-inducible factor-2α; hypoxia-inducible factor-3α; laryngeal carcinoma; vascular endothelial growth factor A

Year:  2015        PMID: 26137164      PMCID: PMC4473705          DOI: 10.3892/ol.2015.3070

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  48 in total

1.  Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve.

Authors:  Jun Yu; Ebo D deMuinck; Zhenwu Zhuang; Mary Drinane; Katalin Kauser; Gabor M Rubanyi; Hu Sheng Qian; Takahisa Murata; Bruno Escalante; William C Sessa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

2.  Expression of hypoxia inducible factor-1α and its significance in laryngeal carcinoma.

Authors:  X-H Wu; Y-F Lu; X-D Hu; J-Y Mao; X-X Ji; H-T Yao; S-H Zhou
Journal:  J Int Med Res       Date:  2010       Impact factor: 1.671

3.  HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin.

Authors:  Masanobu Morita; Osamu Ohneda; Toshiharu Yamashita; Satoru Takahashi; Norio Suzuki; Osamu Nakajima; Shimako Kawauchi; Masatsugu Ema; Shigeki Shibahara; Tetsuo Udono; Koji Tomita; Makoto Tamai; Kazuhiro Sogawa; Masayuki Yamamoto; Yoshiaki Fujii-Kuriyama
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

4.  Expression and significance of hypoxia-inducible factor-1α and glucose transporter-1 in laryngeal carcinoma.

Authors:  Xiao-Hong Wu; Su-Ping Chen; Jian-Ying Mao; Xue-Xian Ji; Hong-Tian Yao; Shui-Hong Zhou
Journal:  Oncol Lett       Date:  2012-09-26       Impact factor: 2.967

5.  Multiple splice variants of the human HIF-3 alpha locus are targets of the von Hippel-Lindau E3 ubiquitin ligase complex.

Authors:  Mindy A Maynard; Heng Qi; Jacky Chung; Eric H L Lee; Yukihiro Kondo; Shuntaro Hara; Ronald C Conaway; Joan W Conaway; Michael Ohh
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

6.  Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.

Authors:  Norihiko Takeda; Koji Maemura; Yasushi Imai; Tomohiro Harada; Daiji Kawanami; Takefumi Nojiri; Ichiro Manabe; Ryozo Nagai
Journal:  Circ Res       Date:  2004-06-10       Impact factor: 17.367

7.  Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

Authors:  H P Gerber; A McMurtrey; J Kowalski; M Yan; B A Keyt; V Dixit; N Ferrara
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

8.  Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.

Authors:  Da-wei Li; Liang Zhou; Bin Jin; Jin Xie; Pin Dong
Journal:  Otolaryngol Head Neck Surg       Date:  2012-10-19       Impact factor: 3.497

9.  Radiotherapy in laryngeal carcinoma: can a panel of 13 markers predict response?

Authors:  Maarten A M Wildeman; Johan H Gibcus; Michael Hauptmann; Adrian C Begg; Marie Louise F van Velthuysen; Frank J Hoebers; Mirjam F Mastik; Ed Schuuring; Jacqueline E van der Wal; Michiel W M van den Brekel
Journal:  Laryngoscope       Date:  2009-02       Impact factor: 3.325

10.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  2 in total

1.  Strong Correlation Between mRNA Expression Levels of HIF-2α, VEGFR1, VEGFR2 and MMP2 in Laryngeal Carcinoma.

Authors:  Todor M Popov; G Stancheva; T E Goranova; J Rangachev; D Konov; S Todorov; O Stoyanov; R P Kaneva; D Popova
Journal:  Pathol Oncol Res       Date:  2016-04-13       Impact factor: 3.201

2.  HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.

Authors:  Yu Zhu; Xuebin Zhang; Lisha Qi; Ying Cai; Ping Yang; Geng Xuan; Yuan Jiang
Journal:  Oncotarget       Date:  2016-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.